Education
About Us
Working with TipRanks
Follow Us
ExpreS2ion Biotech Holding AB (DE:5JD0)
:5JD0
Total Valuation
ExpreS2ion Biotech Holding AB has a market cap or net worth of €5.70M. The enterprise value is €6.80M.
Market Cap€5.70M
Enterprise Value€6.80M
Share Statistics
ExpreS2ion Biotech Holding AB has 2,658,346 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding2,658,346
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
ExpreS2ion Biotech Holding AB’s return on equity (ROE) is -0.57 and return on invested capital (ROIC) is -82.14%.
Return on Equity (ROE)-0.57
Return on Assets (ROA)-0.35
Return on Invested Capital (ROIC)-82.14%
Return on Capital Employed (ROCE)-1.02
Revenue Per Employee150.65K
Profits Per Employee-3.38M
Employee Count20
Asset Turnover0.03
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.
PE Ratio―
PS Ratio0.00
PB Ratio1.26
Price to Fair Value0.54
Price to FCF-1.16
Price to Operating Cash Flow-1.17
PEG Ratio-0.18
Income Statement
In the last 12 months, ExpreS2ion Biotech Holding AB had revenue of 3.01M and earned -36.41M in profits. Earnings per share was -21.54.
Revenue3.01M
Gross Profit-2.67M
Operating Income-67.69M
Pretax Income-44.56M
Net Income-36.41M
EBITDA-64.34M
Earnings Per Share (EPS)-21.54
Cash Flow
In the last 12 months, operating cash flow was -55.13M and capital expenditures -681.00K, giving a free cash flow of -55.81M billion.
Operating Cash Flow-55.13M
Free Cash Flow-55.81M
Free Cash Flow per Share-20.99
Dividends & Yields
ExpreS2ion Biotech Holding AB pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.11
52-Week Price Change-15.59%
50-Day Moving Average1.97
200-Day Moving Average2.05
Relative Strength Index (RSI)54.63
Average Volume (3m)0.00
Important Dates
ExpreS2ion Biotech Holding AB upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
ExpreS2ion Biotech Holding AB as a current ratio of 2.48, with Debt / Equity ratio of 0.66%
Current Ratio2.48
Quick Ratio2.48
Debt to Market Cap0.01
Net Debt to EBITDA1.26
Interest Coverage Ratio-93.12
Taxes
In the past 12 months, ExpreS2ion Biotech Holding AB has paid -8.53M in taxes.
Income Tax-8.53M
Effective Tax Rate0.19
Enterprise Valuation
ExpreS2ion Biotech Holding AB EV to EBITDA ratio is 0.72, with an EV/FCF ratio of 1.33.
EV to Sales-15.38
EV to EBITDA0.72
EV to Free Cash Flow1.33
EV to Operating Cash Flow1.37
Balance Sheet
ExpreS2ion Biotech Holding AB has €58.01M in cash and marketable securities with kr340.00K in debt, giving a net cash position of -€57.66M billion.
Cash & Marketable Securities€58.01M
Total Debtkr340.00K
Net Cash-€57.66M
Net Cash Per Share-€21.69
Tangible Book Value Per Share€36.87
Margins
Gross margin is -405.00%, with operating margin of -2246.76%, and net profit margin of -1208.60%.
Gross Margin-405.00%
Operating Margin-2246.76%
Pretax Margin-1479.02%
Net Profit Margin-1208.60%
EBITDA Margin-2135.41%
EBIT Margin-1454.90%
Analyst Forecast
The average price target for ExpreS2ion Biotech Holding AB is €2.01, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target€2.01
Price Target Upside-9.46% Downside
Analyst ConsensusHold
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―